Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 75, Issue 5, 2016, Pages 933-940

  Miceli Richard, Corinne ^a   Wang Renault, Shu Fang ^b,c   Boudaoud, Saida ^a   Busato, Florence ^b   Lallemand, Céline ^b   Bethune, Kevin ^b   Belkhir, Rakiba ^a   Nocturne, Gaétane ^a   Mariette, Xavier ^a   Tost, Jörg ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD19 ANTIGEN; GAMMA INTERFERON; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; INTERFERON REGULATORY FACTOR 5; LA ANTIBODY; RO ANTIBODY;

ALU SEQUENCE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL ISOLATION; CLINICAL ARTICLE; COL11A2 GENE; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; DEREGULATION; DISEASE ACTIVITY; DNA METHYLATION; DNA STRUCTURE; EPIGENETICS; FEMALE; GENE; GENE LOCUS; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC RISK; GTF2I GENE; HLA DPB1 GENE; HLA DQA1 GENE; HUMAN; HUMAN CELL; IFI44 L GENE; IFITM1 GENE; IFITM3 GENE; IFN ALPHA GENE; IFN GAMMA GENE; IRF5 GENE; LINE1 SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM; SJOEGREN SYNDROME; ADULT; AGED; CASE CONTROL STUDY; CELL CULTURE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

ADULT; AGED; B-LYMPHOCYTE SUBSETS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CPG ISLANDS; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME;

EID: 84937598807     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206998     Document Type: Article

References (34)

1. Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sjogren's syndrome: a systematic review and meta-analysis. Ann Rheum Dis 2015;74:1983-9.
2. Bowman SJ, Ibrahim GH, Holmes G, et al. Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 2004;33:39-43.
3. Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren's syndrome. Nat Rev Rheumatol 2013;9:544-56.
4. Lessard CJ, Li H, Adrianto I, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome. Nat Genet 2013;45:1284-92.
5. Lu Q. The critical importance of epigenetics in autoimmunity. J Autoimmun 2013;41:1-5.
6. Miceli-Richard C, Criswell LA. Genetic, genomic and epigenetic studies as tools for elucidating disease pathogenesis in primary Sjogren's syndrome. Expert Rev Clin Immunol 2014;10:437-44.
7. Nielsen HM, Tost J. Epigenetic changes in inflammatory and autoimmune diseases. Subcell Biochem 2012;61:455-78.
8. Alevizos I, Alexander S, Turner RJ, et al. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjogren's syndrome. Arthritis Rheum 2011;63:535-44.
9. Coit P, Jeffries M, Altorok N, et al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J Autoimmun 2013;43:78-84.
10. Absher DM, Li X, Waite LL, et al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet 2013;9:e1003678.
11. Altorok N, Coit P, Hughes T, et al. Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjogren's syndrome. Arthritis Rheum 2014;66:731-9.
12. Seror R, Theander E, Brun JG, et al. Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 2015;74:859-66.
13. Tost J, Gut IG. Analysis of gene-specific DNA methylation patterns by pyrosequencing technology. Methods Mol Biol 2007;373:89-102.
14. Touleimat N, Tost J. Complete pipeline for Infinium ((R)) Human Methylation 450 K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. Epigenomics 2012;4:325-41.
15. Rusinova I, Forster S, Yu S, et al. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res 2013;41(Database issue):D1040-6.
16. Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci USA 2006;103:2770-5.
17. Hall JC, Casciola-Rosen L, Berger AE, et al. Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proc Natl Acad Sci USA 2012;109:17609-14.
18. Maria NI, Brkic Z, Waris M, et al. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome. Ann Rheum Dis 2014;73:1052-9.
19. Chiche L, Jourde-Chiche N, Whalen E, et al. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheum 2014;66:1583-95.
20. Naves R, Singh SP, Cashman KS, et al. The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 2013;191:2967-77.
21. Yao Y, Richman L, Morehouse C, et al. Type I interferon: potential therapeutic target for psoriasis? PLoS ONE 2008;3:e2737.
22. der SD, Zhou A, Williams BR, et al. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 1998;95:15623-8.
23. Li Y, Zhang K, Chen H, et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren's syndrome at 7q11.23. Nat Genet 2013;45:1361-5.
24. Quintero-Ronderos P, Montoya-Ortiz G. Epigenetics and autoimmune diseases. Autoimmune Dis 2012;2012:593720.
25. Mak A, Kow NY. The pathology of T cells in systemic lupus erythematosus. J Immunol Res 2014;2014:419029.
26. Cornec D, Devauchelle-Pensec V, Tobon GJ, et al. B cells in Sjogren's syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun 2012;39:161-7.
27. Jaffe AE, Irizarry RA. Accounting for cellular heterogeneity is critical in epigenome-wide association studies. Genome Biol 2014;15:R31.
28. Liu Y, Aryee MJ, Padyukov L, et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol 2013;31:142-7.
29. Koelsch KA, Webb R, Jeffries M, et al. Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. J Autoimmunity 2013;41:168-74.
30. Gestermann N, Koutero M, Belkhir R, et al. Methylation profile of the promoter region of IRF5 in primary Sjogren's syndrome. Eur Cytokine Netw 2012;23:166-72.
31. Emamian ES, Leon JM, Lessard CJ, et al. Peripheral blood gene expression profiling in Sjogren's syndrome. Genes Immun 2009;10:285-96.
32. Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003;100:2610-15.
33. Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197:711-23.
34. Rakyan VK, Beyan H, Down TA, et al. Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 2011;7:e1002300.